Pharmalytics Group is an independent, minority-owned health economics and outcomes research (HEOR) and market access consultancy specializing in strategy and advanced analytics to support pharmaceutical market access around the world. Our team is led by methodologists with decades of experience in health technology assessment (HTA), evidence synthesis, real-world evidence, and decision sciences. We are at the forefront of utilizing machine-learning (ML) and artificial intelligence (AI) techniques in our industry to help our clients achieve their market access goals. Our team has supported more than 300 HTA submission globally across more than 175 therapeutic indications. Our experience spans all disease areas, including, but not limited to, oncology, rare diseases, cardiovascular disease, diabetes, metabolic disorders, and infectious diseases. Our team has supported clients in the pharmaceutical, biotech, and medical device industries.Pharmalytics Group is Headquartered in Vancouver, British Columbia, Canada, with satellite offices in Montréal, Québec, Canada, and Hyderabad, Telangana, India. We acknowledge that our primary business operations are located on the traditional territories of the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səlilwətaɬ (Tsleil-Waututh) Nations.